Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533].
Saved in:
| Title: | Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]. |
|---|---|
| Authors: | Wu C; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Xu Q; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China., Wang H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Tu B; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528437, China., Zeng J; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Zhao P; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Center of Clinical Pharmacology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou 310009, China., Shi M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Qiu H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Huang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528437, China.; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai 201203, China.; Taizhou University, School of Advanced Study, Institute of Natural Medicine and Health Product, Taizhou 318000, China. |
| Source: | Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2023 Nov; Vol. 13 (11), pp. 4664-4666. Date of Electronic Publication: 2023 Aug 07. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37969729 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+C%22">Wu C</searchLink>; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Xu+Q%22">Xu Q</searchLink>; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Tu+B%22">Tu B</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528437, China.<br /><searchLink fieldCode="AU" term="%22Zeng+J%22">Zeng J</searchLink>; Artemisinin Research Center, First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Zhao+P%22">Zhao P</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Center of Clinical Pharmacology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou 310009, China.<br /><searchLink fieldCode="AU" term="%22Shi+M%22">Shi M</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Qiu+H%22">Qiu H</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528437, China.; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai 201203, China.; Taizhou University, School of Advanced Study, Institute of Natural Medicine and Health Product, Taizhou 318000, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101600560%22">Acta pharmaceutica Sinica. B</searchLink> [Acta Pharm Sin B] 2023 Nov; Vol. 13 (11), pp. 4664-4666. <i>Date of Electronic Publication: </i>2023 Aug 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101600560 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2211-3835 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222113835%22">22113835 </searchLink><i>NLM ISO Abbreviation: </i>Acta Pharm Sin B <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37969729 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.apsb.2023.08.007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4664 Titles: – TitleFull: Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu C – PersonEntity: Name: NameFull: Xu Q – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Tu B – PersonEntity: Name: NameFull: Zeng J – PersonEntity: Name: NameFull: Zhao P – PersonEntity: Name: NameFull: Shi M – PersonEntity: Name: NameFull: Qiu H – PersonEntity: Name: NameFull: Huang Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2023 Nov Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2211-3835 Numbering: – Type: volume Value: 13 – Type: issue Value: 11 Titles: – TitleFull: Acta pharmaceutica Sinica. B Type: main |
| ResultId | 1 |
